NCT02125513

Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer

Randomized Phase II Study of 3 vs 6 Courses of Neoadjuvant Carboplatin-paclitaxel Chemotherapy in Stage IIIC or IV Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 129 (actual)
• Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to define whether 6 courses of neoadjuvant chemotherapy can lead to a higher rate of complete cytoreductive surgery compared with 3 courses of neoadjuvant chemotherapy in patients with epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.

Conditions

• Ovarian Cancer
• Fallopian Tube Carcinoma
• Peritoneal Carcinoma

Interventions

Type	Name	Description
DRUG	carboplatin and paclitaxel followed by surgery

Timeline

• Start date: 2014-01-01
• Primary completion: 2021-05-25
• Completion: 2023-12-01
• First posted: 2014-04-29
• Last updated: 2022-12-30

Locations

5 sites across 1 country: Italy